WGSGeneDx Holdings

Median target
$90
calls from the last 12 months
Implied return
-14.2%
median target vs. price
Coverage
6 analysts · 6 calls
updated in the last 12 months
Consensus
6/0/0+6 net
Buy / Hold / Sell

Which analysts are behind WGS's consensus?

See every current rating, price target and the analysts' track records for GeneDx Holdings — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 6 analysts with calls on WGS updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

WGS elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-16InsidersStueland KatherineCHIEF EXECUTIVE OFFICERInsider sale4.1K sh @ $98.27$407K
2026-09-16InsidersStueland KatherineCHIEF EXECUTIVE OFFICERInsider sale3.0K sh @ $99.00$301K
2026-09-16InsidersStueland KatherineCHIEF EXECUTIVE OFFICERInsider sale1.6K sh @ $94.26$155K
2026-09-16InsidersStueland KatherineCHIEF EXECUTIVE OFFICERInsider sale1.5K sh @ $96.90$148K
2026-09-16InsidersFeeley KevinCHIEF FINANCIAL OFFICERInsider sale1.5K sh @ $98.27$144K
2026-09-16InsidersFeeley KevinCHIEF FINANCIAL OFFICERInsider sale1.1K sh @ $99.00$107K
2026-09-16InsidersFeeley KevinCHIEF FINANCIAL OFFICERInsider sale586 sh @ $94.26$55K
2026-09-16InsidersFeeley KevinCHIEF FINANCIAL OFFICERInsider sale541 sh @ $96.90$52K
2026-09-16InsidersStueland KatherineCHIEF EXECUTIVE OFFICERInsider sale148 sh @ $95.41$14K
2026-09-16InsidersFeeley KevinCHIEF FINANCIAL OFFICERInsider sale52 sh @ $95.41$5K

More: insider activity · executive branch · trending